DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Nastoupil LJ, Jain MD, Feng L. et al.
Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium.
J Clin Oncol 2020;
38 (27) 3119-3128
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.